• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

CI Global Health Sciences Corporate Class

+ Add to Watchlist

UNISHSCI:CN

49.47 CAD 0.000.00%

As of 07:59:30 ET on 10/24/2014.

Snapshot for CI Global Health Sciences Corporate Class (UNISHSCI)

Year To Date: +11.16% 3-Month: +2.55% 3-Year: +32.32% 52-Week Range: 39.70 - 55.19
1-Month: +0.14% 1-Year: +19.73% 5-Year: +21.32% Beta vs CXBT: 0.73

Mutual Fund Chart for UNISHSCI

No chart data available.
  • UNISHSCI:CN 49.47
  • 1M
  • 1Y
Interactive UNISHSCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UNISHSCI

CI Global Health Sciences Corporate Class is an open-end fund incorporated in Canada. The Fund seeks to obtain maximum long-term capital growth. The Fund invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry.

Inception Date: 07-23-1996 Telephone: 1-800-268-9374
Managers: ANDREW WAIGHT
Web Site: www.ci.com

Fundamentals for UNISHSCI

NAV (on 2014-10-24) 49.47
Assets (M) (on 2014-09-30) 284.82
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 50.00

Dividends for UNISHSCI

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-03-28) 0.70
Dividend Yield (ttm) 1.42

Fees & Expenses for UNISHSCI

Front Load 5.00
Back Load 5.50
Current Mgmt Fee 2.00
Redemption Fee 2.00
12b1 Fee -
Expense Ratio 2.22

Top Fund Holdings for UNISHSCI

Filing Date: 08/29/2014
Name Position Value % of Total
BioMarin Pharmaceutical Inc 237,168 18,364,887 5.482%
Sanofi 145,000 17,295,934 5.163%
Intercept Pharmaceuticals Inc 50,800 16,001,931 4.777%
Air Methods Corp 225,000 14,350,095 4.284%
Boston Scientific Corp 1,029,700 14,195,810 4.238%
Novartis AG 145,000 14,139,934 4.221%
Roche Holding AG 43,400 13,757,955 4.107%
Isis Pharmaceuticals Inc 292,757 12,973,933 3.873%
Kyowa Hakko Kirin Co Ltd 728,064 10,726,963 3.202%
NuVasive Inc 272,750 10,408,834 3.107%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil